Published in Am J Respir Crit Care Med on August 01, 2014
Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis (2015) 0.80
Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. J Cachexia Sarcopenia Muscle (2015) 0.77
Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol (2004) 5.66
Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest (2011) 3.72
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 3.69
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 3.54
Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax (2006) 2.55
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med (2002) 2.41
The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J (2009) 1.71
Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J (2012) 1.52
Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine? Muscle Nerve (2013) 1.03
Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J (2010) 1.03
Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. Thorax (2012) 0.90
Physiological, histological and biochemical properties of rat skeletal muscles in response to hindlimb suspension. J Electromyogr Kinesiol (2006) 0.90
Phenotypic characteristics associated with reduced short physical performance battery score in COPD. Chest (2014) 0.89
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med (2003) 6.82
Acute skeletal muscle wasting in critical illness. JAMA (2013) 6.38
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol (1985) (2008) 4.09
Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 3.69
Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med (2004) 3.10
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Obstructive sleep apnea in patients with typical atrial flutter: prevalence and impact on arrhythmia control outcome. Chest (2013) 2.69
Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax (2012) 2.66
Patent foramen ovale in severe obstructive sleep apnea: clinical features and effects of closure. Chest (2013) 2.65
Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax (2006) 2.55
The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ (2006) 2.20
Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J (2013) 2.20
Surgical approaches for lung volume reduction in emphysema. Clin Med (2014) 2.14
The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference. Eur Respir J (2013) 2.07
Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration (2012) 1.99
Inhaled drugs and global warming: time to shift to dry powder inhalers. BMJ (2013) 1.98
Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med (2002) 1.92
Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.87
Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax (2010) 1.79
Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One (2012) 1.77
Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.74
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest (2011) 1.72
Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act (2012) 1.70
Academic boycott of Israel. Academic boycott of Israel is the least we can do. BMJ (2003) 1.70
Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet (2003) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Resistance exercise-induced increase in muscle mass correlates with p70S6 kinase phosphorylation in human subjects. Eur J Appl Physiol (2007) 1.61
Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med (2014) 1.59
Influence of immersion in water on muscle function and breathing pattern in patients with severe diaphragm weakness. Chest (2004) 1.59
Teratoma occupying the left hemithorax. World J Surg Oncol (2005) 1.58
Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J (2011) 1.58
Effects of written action plan adherence on COPD exacerbation recovery. Thorax (2010) 1.57
Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax (2009) 1.55
The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax (2011) 1.54
Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest (2003) 1.54
The neuropathology of septic shock. Brain Pathol (2004) 1.53
Human respiratory muscle blood flow measured by near-infrared spectroscopy and indocyanine green. J Appl Physiol (1985) (2008) 1.53
Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J (2013) 1.53
Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J (2012) 1.52
Sustained elevation of circulating growth and differentiation factor-15 and a dynamic imbalance in mediators of muscle homeostasis are associated with the development of acute muscle wasting following cardiac surgery. Crit Care Med (2013) 1.51
COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J Public Health (Oxf) (2010) 1.49
Finding the missing millions - the impact of a locally enhanced service for COPD on current and projected rates of diagnosis: a population-based prevalence study using interrupted time series analysis. Prim Care Respir J (2013) 1.49
An Exploratory Study of Long-Term Outcome Measures in Critical Illness Survivors: Construct Validity of Physical Activity, Frailty, and Health-Related Quality of Life Measures. Crit Care Med (2016) 1.45
A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. Chest (2014) 1.43
Methodological aspects of bronchoscopic lung volume reduction with a proprietary system. Respiration (2004) 1.43
[Global muscle dysfunction and exacerbation of COPD: a cohort study]. Med Clin (Barc) (2004) 1.40
[Relationship between expiratory muscle dysfunction and dynamic hyperinflation in advanced chronic obstructive pulmonary disease]. Arch Bronconeumol (2009) 1.40
A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease. Can Respir J (2007) 1.40
Validity of chronic obstructive pulmonary disease diagnoses in a large administrative database. Can Respir J (2012) 1.39
Redox balance and cellular inflammation in the diaphragm, limb muscles, and lungs of mechanically ventilated rats. Anesthesiology (2010) 1.38
[Usefulness of radial endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of mediastinal lymph nodes]. Arch Bronconeumol (2009) 1.38
Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax (2011) 1.35
Physical activity and clinical and functional status in COPD. Chest (2009) 1.34
Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med (2010) 1.32
Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J (2011) 1.31
High pressure versus high intensity noninvasive ventilation in stable hypercapnic chronic obstructive pulmonary disease: a randomized crossover trial. Int J Chron Obstruct Pulmon Dis (2012) 1.31
Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol (2013) 1.29
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc (2011) 1.28
Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet (2003) 1.28
Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.26
Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.23
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med (2011) 1.23
Lung function indices for predicting mortality in COPD. Eur Respir J (2013) 1.23
Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease. Can Respir J (2007) 1.21
Improving physical activity in COPD: towards a new paradigm. Respir Res (2013) 1.20
Exercise-induced respiratory muscle fatigue: implications for performance. J Appl Physiol (1985) (2007) 1.18
The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2005) 1.18
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest (2009) 1.16
Effectiveness of Interval Exercise Training in Patients with COPD. Cardiopulm Phys Ther J (2010) 1.15
Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. J Clin Sleep Med (2011) 1.14
The value of multiple tests of respiratory muscle strength. Thorax (2007) 1.13
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2003) 1.10
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res (2007) 1.10
Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr (2008) 1.10
The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD (2012) 1.09